Details for New Drug Application (NDA): 019212
✉ Email this page to a colleague
NDA 019212 describes THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by B Braun and is included in two NDAs. Additional details are available on the THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 019212
| Tradename: | THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | B Braun |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019212
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/100ML | ||||
| Approval Date: | Nov 7, 1984 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 400MG/100ML | ||||
| Approval Date: | Nov 7, 1984 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 4MG/ML | ||||
| Approval Date: | Nov 7, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
